Eurocine Vaccines expects results from the ongoing immunological analyses in June/July 2017. The samples presently being analyzed were collected during the clinical study on the nasal influenza vaccine candidate Immunose™ FLU, conducted in the current influenza season, 2016/2017.

“I am pleased that the progress of the immunological analyses has been somewhat faster than expected”, said CSO Anna-Karin Maltais.”

Hear Marie Olliver summon the progress of the study in this short video =>

The study can also be followed here www.clinicaltrials.com

Download the Pressrelease here  

Vill du följa Eurocine Vaccines utveckling lättare?

Ta del del av pressreleaser, nyheter och artiklar kring vaccinering och influensa.
Välj vilken information som intresserar dig genom att fylla i fälten nedan.